Gutiérrez-Granados, Sonia
Cervera, Laura
Segura, María de las Mercedes
Wölfel, Jens
Gòdia, Francesc
Funding for this research was provided by:
National Science Foundation (CBET-1067506)
Article History
Received: 27 October 2015
Revised: 26 November 2015
Accepted: 1 December 2015
First Online: 19 December 2015
Compliance with ethical standards
: This article does not contain any studies with animals or human participants performed by any of the authors.
: Jens Wölfel is an employee of CEVEC Pharmaceuticals, the company that has developed the CAP-T cell line and has contributed with scientific advice to this work.